Despite the widespread use of mechanical circulatory support systems, modern optimal drug therapy and various interventional methods of heart transplantation remain the "gold standard" for the treatment of end-stage heart failure patients.At the same time the required number of heart transplants is significantly increasing due to the progressively increasing number of patients needing transplants and the actual donor pool. In recent years there has been a trend towards the increase in the number of recipients and the decrease in the number of donor organs. However, the use of donor hearts with pathological changes, including left ventricular myocardial hypertrophy, remains a controversial topic. It is believed that the use of expanded crite...
Cardiac transplantation is an established therapy for end-stage heart failure. The number of heart t...
Heart transplantation remains the only definite treatment option for end-stage heart diseases. The u...
Hypertrophic cardiomyopathy is a genetic heart disease with heterogeneous clinical features, includi...
Background Heart transplantation (HTx) remains the treatment of choice for patients with end-stage a...
[Abstract] Heart transplantation is advocated in selected patients with advanced heart failure in th...
Cardiac Transplantation remains the definitive treatment of End-Stage Heart Failure beyond medical t...
Heart transplantation provides a substantial survival benefit for selected patients with advanced he...
Heart transplantation is advocated in selected patients with advanced heart failure in the absence o...
A 42 years old woman was admitted to the Cardiology Department for heart failure. The woman had a di...
A heart transplant is at present considered the treatment of choice in cases of terminal cardiac ins...
Heart transplantation (HT) is the sole therapeutic option for selected patients with hypertrophic ca...
For more than 30 years, heart transplantation has been a successful therapy for patients with termin...
Purpose: The purpose of this article is to review how donor heart utilization has evolved over time ...
Full list of author information is available at the end of the articleIntroduction Heart transplanta...
Objective: To study the achievability of device weaning in patients receiving left ventricular assis...
Cardiac transplantation is an established therapy for end-stage heart failure. The number of heart t...
Heart transplantation remains the only definite treatment option for end-stage heart diseases. The u...
Hypertrophic cardiomyopathy is a genetic heart disease with heterogeneous clinical features, includi...
Background Heart transplantation (HTx) remains the treatment of choice for patients with end-stage a...
[Abstract] Heart transplantation is advocated in selected patients with advanced heart failure in th...
Cardiac Transplantation remains the definitive treatment of End-Stage Heart Failure beyond medical t...
Heart transplantation provides a substantial survival benefit for selected patients with advanced he...
Heart transplantation is advocated in selected patients with advanced heart failure in the absence o...
A 42 years old woman was admitted to the Cardiology Department for heart failure. The woman had a di...
A heart transplant is at present considered the treatment of choice in cases of terminal cardiac ins...
Heart transplantation (HT) is the sole therapeutic option for selected patients with hypertrophic ca...
For more than 30 years, heart transplantation has been a successful therapy for patients with termin...
Purpose: The purpose of this article is to review how donor heart utilization has evolved over time ...
Full list of author information is available at the end of the articleIntroduction Heart transplanta...
Objective: To study the achievability of device weaning in patients receiving left ventricular assis...
Cardiac transplantation is an established therapy for end-stage heart failure. The number of heart t...
Heart transplantation remains the only definite treatment option for end-stage heart diseases. The u...
Hypertrophic cardiomyopathy is a genetic heart disease with heterogeneous clinical features, includi...